title: Accelerating skin wound healing by M-CSF through generating SSEA-1 and -3 stem cells in the injured sites.
abstract: Wound healing is a complicated process requiring the collaborative efforts of different cell lineages. Our recent studies have found that one subset of hematopoietic cells can be induced to dedifferentiate into multipotent stem cells by means of a proliferating fibroblast releasable factor, M-CSF. Understanding the importance of stem cells on skin wound healing, here we evaluate the biological significance of M-CSF on skin wound healing. In an in vivo mouse skin excisional wound model, we found that SSEA-positive stem cells were present in wounded but not normal skin. After isolating skin cells from either normal or wounded skin by collagenase digestion, and analyzing the SSEA-1 positive cells by flow cytometry, we found a significant increase in the number of SSEA-1 positive cells in wounded skin. Topical application of M-CSF in skin wounds accelerated healing remarkably, while application of M-CSF-neutralizing antibody slowed wound healing. Furthermore, injection of EGFP-labeled hematopoietic cell-derived stem cells generated from M-CSF treated splenocytes resulted in EGFP-labeled cells being enriched in the skin wound site and further differentiated into functional organ-specific cells. Together, these data demonstrated that M-CSF makes a significant contribution to the healing process by inducing hematopoietic cell dedifferentiation into stem cells.
authors.affiliation: Department of Surgery, University of British Columbia, Vancouver, BC, V5Z 1M9 Canada.
authors.forename: Yunyuan
authors.initials: Y
authors.lastname: Li
authors.affiliation: Department of Surgery, University of British Columbia, Vancouver, BC, V5Z 1M9 Canada.
authors.forename: Reza Baradar
authors.initials: RB
authors.lastname: Jalili
authors.affiliation: Department of Surgery, University of British Columbia, Vancouver, BC, V5Z 1M9 Canada.
authors.forename: Aziz
authors.initials: A
authors.lastname: Ghahary
mesh_terms: D000287:Administration, Topical; D000818:Animals; D015295:Antigens, Tumor-Associated, Carbohydrate / Q000378:metabolism*; D054337:Cell Dedifferentiation; D002478:Cells, Cultured; D004195:Disease Models, Animal; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000378:metabolism; D016256:Lewis X Antigen / Q000378:metabolism*; D016173:Macrophage Colony-Stimulating Factor / Q000008:administration & dosage* / Q000494:pharmacology; D051379:Mice; D055746:Stage-Specific Embryonic Antigens / Q000378:metabolism*; D014945:Wound Healing / Q000187:drug effects*
chemical_list: D015295:Antigens, Tumor-Associated, Carbohydrate; D016256:Lewis X Antigen; D055746:Stage-Specific Embryonic Antigens; C052924:stage-specific embryonic antigen-3; D016173:Macrophage Colony-Stimulating Factor